Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3
Authors:
- 3 November 2005
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 95 (1) , 37-43
Abstract
Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis in estrogen responsive tissues. Estrogen receptors α and β regulate production of VEGF in both breast and endometrial cancer cells. Alternative splicing of ER-α mRNA generates a mixture of transcripts with various exon deletions in normal breast and breast cancer cells and some of these variants are overexpressed in breast cancer. We analyzed the role of exon-deleted variants of ER-α in regulation of VEGF production by simultaneous transient transfection of CHO and MDA-MB-231 cells with a VEGF promoter luciferase construct. Estrogen (10 nM) treatment resulted in a 6-fold increase in luciferase activity in cells transfected with the exon 3 deleted variant (ERΔ3) compared to a 2-fold activity induction in cells transfected with wild type ER-α. Exon 5 and exon 7 deleted variants were unable to induce activation of the VEGF promoter. Using specific deletion constructs of the VEGF promoter linked to luciferase, we showed that the majority of activation by ERΔ3 was restricted to the −70 to −88 bp fragment that contains two Sp1 sites. Site-directed mutagenesis of both Sp1 sites indicated that ERΔ3 activates the VEGF promoter through interaction with Sp1 proteins. ERΔ3, a variant frequently overexpressed in breast cancer, may significantly contribute to the production of VEGF thus resulting in enhanced tumor growth in vivo.Keywords
This publication has 29 references indexed in Scilit:
- Prolactin-induced expression of vascular endothelial growth factor via Egr-1Molecular and Cellular Endocrinology, 2005
- Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteinsOncogene, 2003
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor ExpressionMolecular and Cellular Biology, 2001
- Expression of Estrogen Receptor α mRNA and Protein Variants in Human Endometrial CarcinomaGynecologic Oncology, 1999
- Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expressionOncogene, 1997
- Intratumoral vascularity as a prognostic factor in cancers of the urogenital tractEuropean Journal of Cancer, 1996
- Vascular Permeability Factor (Vascular Endothelial Growth Factor) Expression and Angiogenesis in Cervical NeoplasiaJNCI: Journal of the National Cancer Institute, 1995
- Human estrogen receptor messenger RNA variants in both normal and tumor breast tissuesMolecular and Cellular Endocrinology, 1995
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994